Spain
-
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Phase 2 · randomised · 120 people · 33 sites in 6 countries · Recruiting now
-
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 2 · randomised · 1,109 people · 47 sites in 8 countries · Recruiting now
-
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Phase 2 · randomised · 327 people · 86 sites in 7 countries · Running, not taking new patients
-
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 · 140 people · 48 sites in 8 countries · Recruiting now
-
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 2 · randomised · 80 people · 12 sites in 5 countries · Recruiting now